Clinical trial
In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and…
NCT00144352 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00144352 |
|---|---|
| Title | In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults |
| Official title | The in-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Individuals-a 28 Day Efficacy Trial Involving HIV+ and HIV- Adults. |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Kenya Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria, HIV, AIDS |
| Intervention type | Drug |
| Interventions | sulfadoxine-pyrimethamine |
| Enrollment | 540 |
| Start date | Sep 1, 2002 |
| Completion | Jul 1, 2004 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 5, 2005 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: